This document is a lab report for a SARS-CoV-2 antigen rapid test performed on a female patient born in 1978. The test result was negative, indicating the absence of SARS-CoV-2 viral antigens. The test has limitations and its performance has not been clinically validated for asymptomatic individuals or for serial screening applications. The lab report was reviewed and validated by a technician on June 1, 2022 at 7:59 AM.
This document is a lab report for a SARS-CoV-2 antigen rapid test performed on a female patient born in 1978. The test result was negative, indicating the absence of SARS-CoV-2 viral antigens. The test has limitations and its performance has not been clinically validated for asymptomatic individuals or for serial screening applications. The lab report was reviewed and validated by a technician on June 1, 2022 at 7:59 AM.
This document is a lab report for a SARS-CoV-2 antigen rapid test performed on a female patient born in 1978. The test result was negative, indicating the absence of SARS-CoV-2 viral antigens. The test has limitations and its performance has not been clinically validated for asymptomatic individuals or for serial screening applications. The lab report was reviewed and validated by a technician on June 1, 2022 at 7:59 AM.
LABORATORIO CLINICO LA 116 CENTRO COMERCIAL PLAZA GUANICA Col. Tec. Med. P.R. 0004612-00 11/18/1978 F 1 Pat. No.: 0000342 BO CANO CARR 116 KM 24 HM 7 GUANICA, PR 00653-8442 Paid 5 Cents Physician Name Exp: 4/30/2023 DIRECTOR: LCDA LISBETH LUGO Num: 000061900 LASALLE-RODRIGUEZ, MARINAIDA LIC # 1319 CLIA # 40D2082435 TEL: (787) 821-7697 FAX: (787) 821-7697 Origin / Special Instructions
ª*Ÿ&3Ÿ#¬ 000030018 L001 ENVIO A MISRESULTADOS
Request Reference Ordered On Supervisor
MERCADO-CINTRON, VIRGINIA 6/01/2022 7:26AM LLN BO LA LUNA CALLE 3 CASA 591 C001:004612-000 Reported On M.T. GUANICA, PR 00653-9998 6/01/2022 7:59AM AAVR
Test Units Results Graphic Normal Range
SARS-CoV ANTIGEN RAPID TEST
SARS-CoV-2 ANTIGEN NEGATIVE NEGATIVE BY: CARESTART CareSTART COVID-19Ag rapid Test Does NOT Differentiate Between SARS-CoV-2. Results are for the identification of the SARS-CoV-2 nucleocapsid protein antigen.The antigen is generally detectable in nasopharyngeal or anterior nasal swab specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but the clinical correlation with patient history and other diagnostics information is necessary to determine infection status. Limitations: The performance of this test has not yet been clinically validated for use in patient without signs and symtoms of respiratory infection, of for serial screening applications when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests and performance may differ in these populations. A study to support use for serial testing will be completed. *** The CareSTART Covid-19 Antigen is only for use under the Food and Drug Administration's (FDA) Emergency Use Authorization (EUA) *** TEST VALIDADED BY: L:9305-AA VELEZ 6/01/2022 7:59AM Sample ID: 000085741 Collected: 6/01/2022 7:26AM *Lab Received: 6/01/2022 7:26AM